Diabetes spatial care paths, leading edge HbA1c testing, facilitation thresholds, proactive-preemptive strategic intelligence, and unmanned aerial vehicles in limited-resource countries

Gerald J Kost, Busadee Pratumvinit

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In limited-resource settings, prediabetes and diabetes care demand efficient Spatial Care Paths and effective geospatial optimization of medical services upstream to avoid the economic penalties of untold patient complications downstream. Clever HbA1c technologies placed at the leading edge of primary care in health care small-world networks will improve patient care where multifactorial impediments are identified by facilitation thresholds. We illustrate how to formulate facilitation thresholds and then actuate changes that will solve problems generating the threshold phenomena. It is no longer a question of whether point-of-care HbA1c should be used, in view of numerous studies showing its benefits that we summarize, but instead one of how to effectively design, implement, integrate, and optimize strategies that serve underserved populations. In parallel, professional oversight for HbA1c interferences and variants accompanied by laboratory evaluation will help optimize diagnosis and monitoring. Aerial drones, which currently are used to deliver blood, vaccines, and drugs to inaccessible rural settings, could transport specimens for detailed HbA1c evaluations. By taking advantage of strategic intelligence and moving to primary care, the flow of knowledge emanating directly from patients will help public health nurses, primary care staff, and multidisciplinary physicians, some working via telemedicine, to proactively and preemptively reduce diabetes complications by means of evidence-based, cost-effective decision making closer to patient homes. Innovative monitoring and treatment will fulfill expectations for high-quality efficient personalized care, even self-monitoring essential to the management of a chronic condition, thus transforming standards of care to appropriately embrace and empower point-of-care culture.

Original languageEnglish (US)
Pages (from-to)12-31
Number of pages20
JournalPoint of Care
Volume16
Issue number1
DOIs
StatePublished - Mar 1 2017

Fingerprint

Point-of-Care Systems
Intelligence
Primary Health Care
Public Health Nurses
Prediabetic State
Telemedicine
Vulnerable Populations
Diabetes Complications
Standard of Care
Self Care
Decision Making
Patient Care
Vaccines
Economics
Technology
Delivery of Health Care
Physicians
Costs and Cost Analysis
Pharmaceutical Preparations
Therapeutics

Keywords

  • Acute coronary syndromes
  • Drones
  • Empowerment
  • Evidence-based
  • Geographic information systems
  • Geospatial
  • HbA1c interferences
  • HbA1c variants
  • Microeconomics
  • Point-of-care culture
  • Prediabetes
  • Primary care
  • Small-world networks
  • Telemedicine

ASJC Scopus subject areas

  • Nursing(all)

Cite this

@article{964c7c7c88eb4f5689905662abb149b2,
title = "Diabetes spatial care paths, leading edge HbA1c testing, facilitation thresholds, proactive-preemptive strategic intelligence, and unmanned aerial vehicles in limited-resource countries",
abstract = "In limited-resource settings, prediabetes and diabetes care demand efficient Spatial Care Paths and effective geospatial optimization of medical services upstream to avoid the economic penalties of untold patient complications downstream. Clever HbA1c technologies placed at the leading edge of primary care in health care small-world networks will improve patient care where multifactorial impediments are identified by facilitation thresholds. We illustrate how to formulate facilitation thresholds and then actuate changes that will solve problems generating the threshold phenomena. It is no longer a question of whether point-of-care HbA1c should be used, in view of numerous studies showing its benefits that we summarize, but instead one of how to effectively design, implement, integrate, and optimize strategies that serve underserved populations. In parallel, professional oversight for HbA1c interferences and variants accompanied by laboratory evaluation will help optimize diagnosis and monitoring. Aerial drones, which currently are used to deliver blood, vaccines, and drugs to inaccessible rural settings, could transport specimens for detailed HbA1c evaluations. By taking advantage of strategic intelligence and moving to primary care, the flow of knowledge emanating directly from patients will help public health nurses, primary care staff, and multidisciplinary physicians, some working via telemedicine, to proactively and preemptively reduce diabetes complications by means of evidence-based, cost-effective decision making closer to patient homes. Innovative monitoring and treatment will fulfill expectations for high-quality efficient personalized care, even self-monitoring essential to the management of a chronic condition, thus transforming standards of care to appropriately embrace and empower point-of-care culture.",
keywords = "Acute coronary syndromes, Drones, Empowerment, Evidence-based, Geographic information systems, Geospatial, HbA1c interferences, HbA1c variants, Microeconomics, Point-of-care culture, Prediabetes, Primary care, Small-world networks, Telemedicine",
author = "Kost, {Gerald J} and Busadee Pratumvinit",
year = "2017",
month = "3",
day = "1",
doi = "10.1097/POC.0000000000000122",
language = "English (US)",
volume = "16",
pages = "12--31",
journal = "Point of Care",
issn = "1533-029X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Diabetes spatial care paths, leading edge HbA1c testing, facilitation thresholds, proactive-preemptive strategic intelligence, and unmanned aerial vehicles in limited-resource countries

AU - Kost, Gerald J

AU - Pratumvinit, Busadee

PY - 2017/3/1

Y1 - 2017/3/1

N2 - In limited-resource settings, prediabetes and diabetes care demand efficient Spatial Care Paths and effective geospatial optimization of medical services upstream to avoid the economic penalties of untold patient complications downstream. Clever HbA1c technologies placed at the leading edge of primary care in health care small-world networks will improve patient care where multifactorial impediments are identified by facilitation thresholds. We illustrate how to formulate facilitation thresholds and then actuate changes that will solve problems generating the threshold phenomena. It is no longer a question of whether point-of-care HbA1c should be used, in view of numerous studies showing its benefits that we summarize, but instead one of how to effectively design, implement, integrate, and optimize strategies that serve underserved populations. In parallel, professional oversight for HbA1c interferences and variants accompanied by laboratory evaluation will help optimize diagnosis and monitoring. Aerial drones, which currently are used to deliver blood, vaccines, and drugs to inaccessible rural settings, could transport specimens for detailed HbA1c evaluations. By taking advantage of strategic intelligence and moving to primary care, the flow of knowledge emanating directly from patients will help public health nurses, primary care staff, and multidisciplinary physicians, some working via telemedicine, to proactively and preemptively reduce diabetes complications by means of evidence-based, cost-effective decision making closer to patient homes. Innovative monitoring and treatment will fulfill expectations for high-quality efficient personalized care, even self-monitoring essential to the management of a chronic condition, thus transforming standards of care to appropriately embrace and empower point-of-care culture.

AB - In limited-resource settings, prediabetes and diabetes care demand efficient Spatial Care Paths and effective geospatial optimization of medical services upstream to avoid the economic penalties of untold patient complications downstream. Clever HbA1c technologies placed at the leading edge of primary care in health care small-world networks will improve patient care where multifactorial impediments are identified by facilitation thresholds. We illustrate how to formulate facilitation thresholds and then actuate changes that will solve problems generating the threshold phenomena. It is no longer a question of whether point-of-care HbA1c should be used, in view of numerous studies showing its benefits that we summarize, but instead one of how to effectively design, implement, integrate, and optimize strategies that serve underserved populations. In parallel, professional oversight for HbA1c interferences and variants accompanied by laboratory evaluation will help optimize diagnosis and monitoring. Aerial drones, which currently are used to deliver blood, vaccines, and drugs to inaccessible rural settings, could transport specimens for detailed HbA1c evaluations. By taking advantage of strategic intelligence and moving to primary care, the flow of knowledge emanating directly from patients will help public health nurses, primary care staff, and multidisciplinary physicians, some working via telemedicine, to proactively and preemptively reduce diabetes complications by means of evidence-based, cost-effective decision making closer to patient homes. Innovative monitoring and treatment will fulfill expectations for high-quality efficient personalized care, even self-monitoring essential to the management of a chronic condition, thus transforming standards of care to appropriately embrace and empower point-of-care culture.

KW - Acute coronary syndromes

KW - Drones

KW - Empowerment

KW - Evidence-based

KW - Geographic information systems

KW - Geospatial

KW - HbA1c interferences

KW - HbA1c variants

KW - Microeconomics

KW - Point-of-care culture

KW - Prediabetes

KW - Primary care

KW - Small-world networks

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=85014456686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014456686&partnerID=8YFLogxK

U2 - 10.1097/POC.0000000000000122

DO - 10.1097/POC.0000000000000122

M3 - Article

VL - 16

SP - 12

EP - 31

JO - Point of Care

JF - Point of Care

SN - 1533-029X

IS - 1

ER -